Category: Kips Bay Medical Inc.Syndicate content

Kips Bay Medical turns to founder Villafana

March 27, 2015 by Brad Perriello

Manny Villafana, who founded St. Jude Medical and Kips Bay Medical, joins a last-gasp, $3 million funding round for Kips Bay.

Kips Bay Medical turns to founder Villafana

Kips Bay Medical slashes workforce

January 7, 2015 by Brad Perriello

Kips Bay Medical says it's laying off nearly 40% of its workforce as it restructures to focus on its eSVS mesh for bypass grafts.

Kips Bay Medical slashes workforce

Medtech leaders talk mistakes, challenges and opportunities at DeviceTalks

July 16, 2014 by Arezu Sarvestani

Top execs from Haemonetics, Kips Bay and others open up about their biggest regrets, debate market pressures facing the medtech industry and offer advice for young entrepreneurs.

Medtech CEOs talk mistakes, challenges and opportunities at DeviceTalks

A group of medtech insiders gathered in Boston last night to talk shop, share stories and glean insight from some of the industry's brightest minds at MassDevice's DeviceTalks East conference.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Integra Lifesciences gains after FDA OKs plant | Wall Street Beat

August 15, 2013 by Brad Perriello

An FDA inspection clears a Plainsboro, N.J. plant that triggered a warning letter for Integra LifeSciences, sending share prices up today.

MassDevice.com Wall Street Beat

Integra LifeSciences (NSDQ:IART) shares are up today after the medical device company revealed that FDA inspectors yesterday cleared a New Jersey plant that was the subject of a 2011 warning letter.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Kips Bay rises on FDA trial approval, despite losses in sales and revenue

March 29, 2013 by Arezu Sarvestani

Kips Bay reports widening losses and shrinking sales for its 4th quarter, but the FDA's decision to allow full enrollment in the U.S. arm of the company's feasibility trial is an important turnaround for the device maker.

Kips Bay logo

Medical device maker Kips Bay Medical (NSDQ:KIPS) saw widening losses and sinking sales during its most recent quarter, but the company marked an important win with FDA approval to complete full enrollment in the U.S. arm of a feasibility study.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Cardiovascular Systems prices $33M offering | Wall Street Beat

March 20, 2013 by Brad Perriello

Cardiovascular Systems prices an offering of 2 million shares at $17.60 apiece, saying it expects to net about $33 million from the deal for "working capital and general corporate purposes," likely including its ORBIT II atherectomy trial.

MassDevice.com Wall Street Beat

Cardiovascular Systems (NSDQ:CSII) priced a public offering of some 2 million shares of CSII stock at $17.60 apiece, saying it expects to net about $33 million from the deal.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Holaira raises $10M for lung device | Wall Street Beat

February 11, 2013 by MassDevice staff

Holaira says it raised $10 million from existing investors for its lung denervation system to treat chronic obstructive pulmonary disease.

MassDevice.com Wall Street Beat

Medical device company Holaira said it drummed up $10 million, changed its name and moved its headquarters.

Formerly known as Innovative Pulmonary Solutions, Holaira said it plans to use the Series C round to develop its minimally invasive devices to treat obstructive lung disease. All of Holaira's existing backers participated, namely Advanced Technology Ventures, Morgenthaler Ventures, Split Rock Partners, and Versant Ventures.